Isaac T Schiefer

Affiliations: 
University of Toledo, Toledo, OH, United States 
Area:
CNS drug discovery
Google:
"Isaac Schiefer"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fà M, Zhang H, Staniszewski A, et al. (2015) Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Trippier PC, Zhao KT, Fox SG, et al. (2014) Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosis. Acs Chemical Neuroscience. 5: 823-9
Schiefer IT, Tapadar S, Litosh V, et al. (2013) Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors. Journal of Medicinal Chemistry. 56: 6054-68
Schiefer IT, VandeVrede L, Fa' M, et al. (2012) Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents. Journal of Medicinal Chemistry. 55: 3076-87
Abdul-Hay S, Schiefer IT, Chandrasena RE, et al. (2011) NO-SSRIs: Nitric Oxide Chimera Drugs Incorporating a Selective Serotonin Reuptake Inhibitor. Acs Medicinal Chemistry Letters. 2: 656-661
Abdelhamid R, Luo J, Vandevrede L, et al. (2011) Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a novel GPR30-dependent Mechanism. Acs Chemical Neuroscience. 2: 256-268
Schiefer IT, Abdul-Hay S, Wang H, et al. (2011) Inhibition of amyloidogenesis by nonsteroidal anti-inflammatory drugs and their hybrid nitrates. Journal of Medicinal Chemistry. 54: 2293-306
Sinha V, Wijewickrama GT, Chandrasena RE, et al. (2010) Proteomic and mass spectroscopic quantitation of protein S-nitrosation differentiates NO-donors. Acs Chemical Biology. 5: 667-80
Anand S, Schiefer IT, Thatcher GRJ. (2010) Nitric oxide donor and mimetic molecules in cancer chemotherapy and chemoprevention Forum On Immunopathological Diseases and Therapeutics. 1: 251-279
See more...